SOLUBLE INTERLEUKIN-2 RECEPTOR SERUM LEVELS IN MYCOSIS-FUNGOIDES - CORRELATION WITH CLINICAL STAGE

被引:0
|
作者
SZEIMIES, RM [1 ]
RUEFF, F [1 ]
KAUDEWITZ, P [1 ]
机构
[1] UNIV MUNICH,DEPT DERMATOL,DERMATOL KLIN & POLIKLIN,FRAUENLOBSTR 9-11,W-8000 MUNICH 2,GERMANY
关键词
MYCOSIS FUNGOIDES; SOLUBLE INTERLEUKIN-2 RECEPTOR; CUTANEOUS T-CELL LYMPHOMA; CLINICAL STAGING;
D O I
10.1002/1097-0142(19921101)70:9<2338::AID-CNCR2820700921>3.0.CO;2-T
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. In a variety of non-Hodgkin lymphomas, a correlation between soluble interleukin-2 receptor levels (sIL-2R) and clinical stage is demonstrable. In mycosis fungoides (MF), two findings raise the question as to a similar correlation: (1) a proportion of tumor cells express IL-2 receptor and (2) sIL-2R is detectable in serum. Methods. sIL-2R were measured in patients with MF (n = 88) and atopic dermatitis (AD) (n = 14) by the enzyme immunoassay technique. Patients with AD served as controls. Cases of MF were classified according to the TNM staging classification. Results. Sera of patients with MF with stages III, IVa, and IVb showed significantly higher values than those of stage I or II and controls. Conclusions. Although a close and significant correlation was found between sIL-2R levels and stage of disease in MF, it is still not clear whether elevated sIL-2R levels reflect disease activity or T-cell activation due to concomitant immunologic processes.
引用
收藏
页码:2338 / 2341
页数:4
相关论文
共 50 条
  • [11] Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma
    Ihn, H
    Sato, S
    Fujimoto, M
    Kikuchi, K
    Takehara, K
    BRITISH JOURNAL OF DERMATOLOGY, 1996, 134 (05) : 843 - 847
  • [12] Soluble interleukin-2 receptor α and interleukin-2 serum levels in patients with basal cell carcinoma
    Sobjanek, Michal
    Bien, Ewa
    Zablotna, Monika
    Sokolowska-Wojdylo, Malgorzata
    Sikorska, Monika
    Lange, Magdalena
    Nowicki, Roman
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2016, 33 (04): : 263 - 268
  • [13] ELEVATED SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS IN SERUM AND INTERLEUKIN-2 RECEPTOR EXPRESSION IN RETINITIS-PIGMENTOSA
    WILLIAMS, LL
    SHANNON, BT
    CHAMBERS, RB
    FASEB JOURNAL, 1991, 5 (04): : A635 - A635
  • [14] CORRELATION OF INTERLEUKIN-2 AND SOLUBLE INTERLEUKIN-2 RECEPTOR WITH CLINICAL ACTIVITY OF MULTIPLE-SCLEROSIS
    SHARIEF, MK
    THOMPSON, EJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1993, 56 (02): : 169 - 174
  • [15] SERUM LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR IN HODGKIN DISEASE - RELATIONSHIP WITH CLINICAL STAGE, TUMOR BURDEN, AND TREATMENT OUTCOME
    AMBROSETTI, A
    NADALI, G
    VINANTE, F
    CARLINI, S
    VENERI, D
    TODESCHINI, G
    MOROSATO, L
    DESABATA, D
    CHILOSI, M
    MAGGI, E
    PARRONCHI, P
    ROMAGNANI, S
    SEMENZATO, G
    PERONA, G
    PIZZOLO, G
    CANCER, 1993, 72 (01) : 201 - 206
  • [16] The serum levels of soluble interleukin-2 receptor levels in patients with obstructive jaundice
    Yuceyar, H
    Kokuludag, A
    Coker, A
    Ersoz, G
    Keskinoglu, A
    Guler, A
    Cavusoglu, H
    HEPATO-GASTROENTEROLOGY, 1996, 43 (10) : 949 - 953
  • [17] Serum soluble interleukin-2 receptor levels in patients with breast cancer
    Murakami S.
    Hirayama R.
    Satomi A.
    Okubo K.
    Matsuki M.
    Sakata H.
    Tsuji Y.
    Breast Cancer, 1997, 4 (1) : 25 - 28
  • [18] INCREASE IN SOLUBLE INTERLEUKIN-2 RECEPTOR AND NEOPTERIN SERUM LEVELS DURING IMMUNOTHERAPY OF CANCER WITH INTERLEUKIN-2
    LISSONI, P
    TISI, E
    BRIVIO, F
    BARNI, S
    ROVELLI, F
    PEREGO, M
    TANCINI, G
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (08) : 1014 - 1016
  • [19] Elevated serum levels of soluble interleukin-2 receptor in juvenile dermatomyositis
    Kobayashi, I
    Ono, S
    Kawamura, N
    Okano, M
    Kobayashi, K
    PEDIATRICS INTERNATIONAL, 2001, 43 (01) : 109 - 111
  • [20] SERUM LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR IN SYSTEMIC AND CIRCUMSCRIBED SCLERODERMA
    ZILLIKENS, D
    BLUM, C
    DUMMER, R
    HARTMANN, AA
    BURG, G
    DERMATOLOGY, 1992, 184 (03) : 233 - 234